ZURICH (Reuters) - Roche will stop development of a drug for treating diabetes partly due to its undesired side effects, marking a high-profile setback for the Swiss company outside its cancer drug comfort zone. (Source: Reuters: Health)
Source: http://www.medworm.com/index.php?rid=7409514&cid=u_0_26_f&fid=23271&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Freuters%2FhealthNews%2F%7E3%2F8iS3FOu2ddY%2Fstory01.htm
phlebotomy programs phlebotomy training az phlebotomy training in az
No comments:
Post a Comment